LSD and DOB: Interaction with 5-HT2A receptors to inhibit NMDA receptor-mediated transmission in the rat prefrontal cortex

European Journal of Neuroscience

Volumn 11, Issue 9, 1999, Pages 3064-3072

  Arvanov, Viktor L ^a   Liang, Xiaofu ^a   Russo, Angelo ^a   Wang, Rex Y ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

5 HT2A receptors; Ca2+ CaM KII; Hallucinogens; Medial prefrontal cortex; NMDA receptors

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; ANILINE; BENZYLAMINE DERIVATIVE; CALMODULIN; CHELERYTHRINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; INDOLEAMINE; KETANSERIN; LYSERGIDE; N (6 AMINOHEXYL) 5 CHLORO 1 NAPHTHALENESULFONAMIDE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N [2 [[N [3 (4 CHLOROPHENYL) 2 PROPENYL] N METHYLAMINO]METHYL]PHENYL] N (2 HYDROXYETHYL) 4 METHOXYBENZENESULFONAMIDE; PIPERIDINE DERIVATIVE; PROPYLAMINE; PROTEIN KINASE C INHIBITOR; PSYCHEDELIC AGENT; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR; SEROTONIN 1D RECEPTOR; SEROTONIN 1E RECEPTOR; SEROTONIN 1F RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN 3 ANTAGONIST; SEROTONIN 6 RECEPTOR; SEROTONIN 7 RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CALCIUM TRANSPORT; COGNITION; CONTROLLED STUDY; ELECTROSTIMULATION; MALE; NONHUMAN; PERCEPTION; PREFRONTAL CORTEX; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; SENSORY SYSTEM; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

EID: 0032823751     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.1999.00726.x     Document Type: Article

References (55)

1. Aghajanian, G.K. & Bing, O.H.L. (1964) Persistence of lysergic acid diethylamide in the plasma of human subjects. Clin. Pharmacol. Ther., 5, 611-614.
2. Aghajanian, G.K. & Marek, G.J. (1997) Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells. Neuropharmacology, 36, 589-599.
3. Anis, N.A., Berry, S.C., Burton, N.R. & Lodge, D. (1983) The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurons by N-methyl-aspartate. Br. J. Pharmacol., 79, 565-575.
4. 1A receptors mediate opposing responses on membrane excitability in rat associate cortex. Neuroscience, 40, 399-412.
5. Arvanov, V.L. & Wang, R.Y. (1997) NMDA-evoked response in pyramidal neurons of the rat medial prefrontal cortex slices consists of NMDA and non-NMDA components. Brain Res., 768, 361-364.
6. 2A receptor antagonist and a potential antipsychotic drug, facilitates NMDA-receptor mediated neurotransmission in the rat medial prefrontal cortical neurons in vitro. Neuropsychopharmacology, 18, 197-209.
7. Arvanov, V.L., Liang, X., Schwartz, J., Grossman, S. & Wang, R.Y. (1997) Clozapine and haloperidol modulate NMDA- and non-NMDA-receptor mediated transmission in rat prefrontal cortical neurons in vitro. J. Pharmacol. Exp. Ther., 283, 226-234.
8. 2A, 2C receptor agonist DOB on NMDA-evoked responses in the rat medial prefrontal cortex. Eur. J. Neurosci., 11, 2917-2934.
9. 2 receptors in the rat medial prefrontal cortex. J. Pharmacol. Exp. Ther., 252, 171-178.
10. B receptor antagonists: from synthesis to therapeutic applications. Trends Pharmacol. Sci., 14, 391-394.
11. 3 receptor antagonist with anxiolytic-like properties. Psychopharmacology, 110, 257-264.
12. Cauller, L.J. & Connors, B.W. (1994) Synaptic physiology of horizontal afferents to layer I in slices of rat SI neocortex. J. Neurosci., 14, 751-762.
13. Davies, M.F., Deisz, R.A., Prince, D.A. & Peroutka, S.J. (1987) Two distinct effects of 5-hydroxytryptamine on single cortical neurons. Brain Res., 423, 347-352.
14. Finkel, A.S. & Redman, S.J. (1985) Optimal voltage clamping with single microelectrodes. In Smith, T.G., Lecar, A. Redman, S.J. & Gage, P.W. (eds), Voltage and Patch Clamping with Microelectrodes. Williams & Wilkins, Baltimore, pp. 95-120.
15. Fox, K. & Daw, N.W. (1993) Do NMDA receptors have a critical function in visual cortical plasticity? Trends Neurosci., 16, 116-122.
16. 2 involvement in the mechanism of action of hallucinogenic agents. Life Sci., 35, 2505-2511.
17. 1A receptors in rat brain membranes. Eur. J. Pharmacol. Molec. Pharmacol., 288, 173-186.
18. 2 receptors in the rat medial prefrontal cortex: behavioral studies. Soc. Neurosci. Abstr., 18, 363.
19. Halliwell, J.V. & Adams, P.R. (1982) Voltage-clamp analysis of muscarinic excitation in hippocampal neurons. Brain Res., 250, 71-92.
20. Hawks, R.L. & Chiang, C.N. (1986) Urine testing for drugs of abuse. In National Institute on Drug Abuse, Research Monograph no. 73. US Department of Health and Human Services, DHHS Publication no. (ADDM), Rockville, MD, pp. 87-1481.
21. Herbert, J.M., Augereau, J.M., Gleye, J. & Maffrand, J.P. (1990) Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun., 172, 993-999.
22. Hicks, T.P. (1995) The role of glutamate and its receptors in synaptic transmission. In Stone, T.W. (ed.), CNS Neurotransmitters and Neuromodulators: Glutamate. CRC Press, New York, pp. 323-359.
23. Hofmann, A. (1975) The chemistry of LSD and its modifications. In Siva Sankar, D.V. (ed.), LSD: A Total Study. PJD Publications, Westbury, NY, pp. 107-140.
24. Holmes, K., Keele, B., Arvanov, V. & Shinnick-Gallagher, P. (1996) Metabotropic glutamate receptor agonist-induced hyperpolarization in rat basolateral amygdala neurons: receptor characterization, second messengers and ion channels. J. Neurophysiol., 76, 3059-3069.
25. 2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites. Proc. Natl Acad. Sci. USA, 95, 735-740.
26. 2A antagonist with a favorable CNS safety profile. J. Pharmacol. Exp. Ther., 277, 968-981.
27. 3 receptor agonist SR 57227A and 5-HT: Intracellular studies. Synapse, 29, 257-286.
28. Lodge, D. (1989) Modulation of N-methyl aspartate receptor-channel complexes. Drugs Today, 25, 395-411.
29. 2 receptors. Mol. Pharmacol., 31, 194-199.
30. Madison, D.V., Lancaster, B. & Nicoll, R.A. (1987) Voltage clamp analysis of cholinergic action in the hippocampus. J. Neurosci., 7, 733-741.
31. 2A receptors on interneurons in rat piriform cortex. J. Pharmacol. Exp. Ther., 278, 1373-1383.
32. Marek, G.J. & Aghajanian, G.K. (1998) Indoleamine and the phenethylamine hallucinogens: mechanisms of psychotomimetic action. Drug Alcohol Dependence, 51, 189-198.
33. 2+-dependent protein kinase inhibition by R-24571, a calmodulin antagonist. Biochem. Pharmacol., 33, 125-130.
34. 3H-ketanserin. J. Neurosci., 9, 3482-3490.
35. 2 receptor by in situ hybridization histochemistry: correlation with the distribution of receptor binding sites. Brain Res., 524, 139-143.
36. Nichols, D.E. (1981) Structure-activity relationships of phenethylamine hallucinogens. J. Pharm. Sci., 70, 839-849.
37. Pazos, A., Cortes, R. & Palacios, J.M. (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors. Brain Res., 346, 231-249.
38. 77Br.]4-bromo-2,5-dimethoxyamphetamine labels a novel 5-hydroxytryptamine-binding site in brain membranes. Mol. Pharmacol., 34, 537-542.
39. 2 receptors. Neuropsychopharmacology; 3, 503-508.
40. Pieri, L., Keller, H.H., Burkard, W. & DaPrada, M. (1978) Effects of lisuride and LSD on cerebral monoamine systems and hallucinosis. Nature, 272, 278-280.
41. 2C receptors. Mol. Brain Res., 23, 163-178.
42. Rainnie, D.G., Holmes, K.H. & Shinnick-Gallagher, P. (1994) Activation of postsynaptic metabotropic glutamate receptors by trans-ACPD hyperpolarizes neurons of the basolateral amygdala. J. Neurosci., 14, 7208-7220.
43. 2 receptors coupled to phospholipase C in rat aorta: Modulation of phosphoinositide turnover by phorbol ester. J. Pharmacol. Exp. Ther., 238, 480-485.
44. Sanders-Bush, E., Burris, K.D. & Knoth, K. (1988) Lysergic acid diethylamide and 2,5-dimethylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis. J. Pharmacol. Exp. Ther., 246, 924-928.
45. Schweitzer, P., Madamba, S., Champagnat, J. & Siggins, G.R. (1993) Somatostatin inhibition of hippocampal CA1 pyramidal neurons: mediation by arachidonic acid and its metabolites. J. Neurosci., 13, 2033-2049.
46. Strassman, R.J. & Qualls, C.R. (1994) Dose-response study of N.N-dimethyltryptamine in humans. I. Neuroendocrine, automatic, and cardiovascular effects. Arch. Gen. Psychiat., 51, 85-97.
47. Strassman, R.J., Quails, C.R., Uhlenhuth, E.H. & Kellner, R. (1994) Dose-response study of N.N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale. Arch. Gen. Psychiat., 51, 98-108.
48. 2+/calmodulin dependent protein kinase II inhibitor KN-93 reduces dopamine contents in PC12h cells. Biochem. Biophys. Res. Commun., 181, 968-975.
49. Tanaka, E. & North, A. (1993) Actions of 5-HT on neurons of rat cingulate cortex. J. Neurophysiol., 69, 1749-1757.
50. 2 agonist radioligand. Biochem. Pharmacol., 36, 3265-3271.
51. Wang, R.Y. & Liang, X. (1998) M100907 and clozapine, but not haloperidol or raclopride, prevent phencyclidine-induced blockade of NMDA responses in pyramidal neurons of the rat medial prefrontal cortical slice. Neuropsychopharmacology, 19, 74-85.
52. 2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats. J. Pharmacol. Exp. Ther., 282, 699-706.
53. 2A receptors are expressed on pyramidal cells and interneurons in the rat cortex. Synapse, 27, 79-82.
54. Witkin, J.M. (1995) Role of NMDA receptors in behavior and behavioral effects of drugs. In Stone, T.W. (ed.) CNS Neurotransmitters and Neuromodulators: Glutamate. CRC Press, New York, pp. 323-359.
55. Wuarin, J.P., Peacock, W.J. & Dubek, F.E. (1992) Single-electrode voltage clamp analysis of the N-methyl-D-aspartate component of synaptic responses in neocortical slices from children with intractable epilepsy. J. Neurophysiol., 67, 84-93.